RainDance Technologies Appoints Patrick Kelly As European Sales Director

RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, has appointed Patrick Kelly to the newly created position of European Sales Director, effective immediately.

“Mr. Kelly’s appointment represents an important step in the geographic expansion of our commercial efforts with the first quarter release of our Sequence Enrichment Solution for the targeted sequencing of the human genome,” said Stephen E. Becker, Vice President, Commercial Operations, RainDance Technologies. “His international business experience in life sciences and genetics and sequencing makes him the ideal candidate to lead RainDance’s entry into the European market.”

Based in Manchester, England, Mr. Kelly will be responsible for introducing RainDance’s RainStorm^TM technology platform to Europe. He will work with thought leaders in genomics research to adopt RainDance’s Sequence Enrichment Solution and the RDT 1000 instrument. In addition, Mr. Kelly will build the commercial sales infrastructure required to launch the company’s solutions in the European market.

Mr. Kelly joins RainDance from Helicos Biosciences where he served as Global Business Manager for the company’s European operations. In this role, he led the positioning of the company’s next-generation sequencing technology with opinion leaders in the region. Mr. Kelly previously was Business Team Manager, Europe, Middle East, Africa, for Agilent Technologies. He also was European Site Manager and Vice President, Sales and Support, for Affymetrix Europe, where he led commercial activities for microarray systems and reagents in the research, pharmaceutical, and molecular diagnostics markets, and served as European Sales Manager for genetic analysis systems at Applied Biosystems. Mr. Kelly received a Bachelor of Science degree in Chemistry from Sheffield University and is a member of the Institute of Directors (UK).

About RainDance Technologies, Inc.

RainDance Technologies Inc. is a provider of innovative microdroplet-based solutions for human health and disease research. The speed and simplicity of the company’s exciting new technology platform enable researchers to design experiments in ways that were previously unaffordable or unimaginable. The company’s RainStorm^tm technology produces picoliter-volume droplets at a rate of 10 million per hour. Each droplet is the functional equivalent of an individual test tube and can contain a single molecule, reaction, or cell. This versatile technology can adapt proven assays for high-speed workflows with minimized process-induced bias or error.

RainDance’s initial application will focus on the targeted sequencing of the human genome — one of the fastest-growing segments of the $1 billion DNA sequencing market. This application will enable the high-resolution analysis of genetic variation between individuals and populations at a level unmatched by current methodology.

RainDance was founded in 2004 by scientists from Harvard University; the Medical Research Centre in Cambridge, England and the ESPCI in Paris.

For more information, please visit www.RainDancetech.com.

Download photo for publication from: www.flickr.com/photos/10956940@N08/3231683892/

RainStorm^tm is a trademark of RainDance Technologies, Inc.

Contacts:

Press inquiries:
Tiziani Whitmyre
Don Goncalves, 781-793-9380
[e-mail]
or
Corporate questions:
RainDance Technologies
Steve Becker, 781-861-6300
[e-mail]
or
In Europe:
RainDance Technologies
Patrick Kelly, [phone]
[e-mail]
or
Technical questions:
RainDance Technologies
Jeremy Lambert, 781-861-6300
[e-mail]